The decrease in the levels of PRF1, a key effector molecule for cytolysis mediated by T and NK cells, in presence of CD8A and CD56 expression in PDAC suggests that the cytotoxic activity or the number of CD8+ T and NK cells may be reduced in the tumor. Here, NCAM1 is linked to neoplasm.